Profound Medical (PROF) Enterprise Value (2018 - 2026)

Profound Medical's Enterprise Value history runs 9 years deep, the most recent figure standing at -$50.3 million for Q1 2026.

• In Q1 2026, Enterprise Value fell 8.32% year-over-year to -$50.3 million; the TTM figure through Mar 2026 stood at -$50.3 million (down 8.32% YoY), while the FY2025 annual figure was -$59.7 million, down 8.76% from the prior year.
• Enterprise Value was -$50.3 million for Q1 2026 at Profound Medical, up from -$59.7 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$24.8 million in Q3 2025 to a low of -$59.7 million in Q4 2025.
• Historically, Enterprise Value has averaged -$43.0 million across 5 years, with a median of -$46.5 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Enterprise Value jumped 43.65% in 2023, then slumped 109.48% in 2024.
• A 5-year view of Enterprise Value shows it stood at -$46.5 million in 2022, then surged by 43.65% to -$26.2 million in 2023, then sank by 109.48% to -$54.9 million in 2024, then declined by 8.76% to -$59.7 million in 2025, then rose by 15.79% to -$50.3 million in 2026.
• The last three Enterprise Value figures came in at -$50.3 million (Q1 2026), -$59.7 million (Q4 2025), and -$24.8 million (Q3 2025), per Business Quant data.